B

C

BORG , Christophe

Last name: BORG

First name: Christophe

March 2012 (v1)

Journal article

Metadata-only

Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.

Bennouna, Jaafar Borg, Christophe Delord, Jean-Pierre

BACKGROUND: This prospective phase II study assessed the efficacy and safety of bevacizumab plus chemotherapy regimens commonly used in the second-line treatment of metastatic colorectal cancer (mCRC). METHODS: Patients with mCRC who progressed or relapsed after first-line oxaliplatin-based or irinotecan-based treatment received bevacizumab 2.5...

Uploaded on: December 4, 2022